3-Methoxybenzanthrone is a synthetic organic compound that has attracted attention due to its potential applications in various fields, including organic electronics, fluorescence imaging, and as a precursor for other valuable compounds. It exhibits strong fluorescence properties, making it suitable for use in fluorescent probes and sensors. The compound is typically synthesized through a multi-step process involving Friedel-Crafts acylation and subsequent cyclization reactions. Research efforts focus on understanding its photophysical properties, exploring its potential as an organic semiconductor material, and investigating its interactions with biological systems.'
| ID Source | ID |
|---|---|
| PubMed CID | 77267 |
| SCHEMBL ID | 3380389 |
| MeSH ID | M0082373 |
| Synonym |
|---|
| 7h-benz[de]anthracen-7-one, 3-methoxy- |
| e1tv38vz4c , |
| unii-e1tv38vz4c |
| EU-0066739 |
| c.i. 58900 |
| einecs 222-992-6 |
| 7h-benz(de)anthracen-7-one, 3-methoxy- |
| 3-methoxybenzanthrone |
| 3-methoxy-7h-benz(de)anthracen-7-one |
| duranol brilliant yellow g |
| acetate yellow 6g |
| c.i. disperse yellow 13 |
| disperse yellow 13 |
| celliton brilliant yellow 8g |
| brn 2055284 |
| duranol brilliant yellow 6g |
| disperse yellow 6z |
| AKOS000592561 |
| 3688-79-7 |
| SCHEMBL3380389 |
| 3-methoxybenzo[b]phenalen-7-one |
| CCG-103163 |
| 3-methoxy-7h-benz[de]anthracen-7-one |
| STL363244 |
| 3-methoxy-7h-benzo[de]anthracen-7-one |
| DTXSID7063136 |
| 3-methoxy-7-oxo-7h-benz(de)anthracene |
| ci 58900 |
| ci disperse yellow 13 |
| sr-01000389302 |
| SR-01000389302-1 |
| BGQDCDRDPCVLJE-UHFFFAOYSA-N |
| Q27276759 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 8 (72.73) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.45) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 14 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||